Nadia Bertola

25PUBLICATIONS
72CO-AUTHORS
Immunogenetics (incl. genetic immunology)Liquid biopsiesPredictive and prognostic markersMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Mar 24, 2026
Immunogenetic Architecture of Chronic Lymphocytic Leukemia at Early Stage: Insights from the O-CLL1 Cohort.

Davide Bagnara, Andrea Nicola Mazzarello, Monica Colombo

|Feb 13, 2026
Intraclonal Enrichment of IL-23 Receptor Complex Expression in the Proliferative Fraction of Chronic Lymphocytic Leukemia.

Martina Cardillo, Fabiana Ferrero, Nadia Bertola

|Jun 26, 2025
Targeting the p53/xCT/GSH Axis with PRIMA-1<sup>Met</sup> Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia.

Martina Pasino, Andrea Speciale, Silvia Ravera

|Jan 08, 2025
IGF-1 Signaling Modulates Oxidative Metabolism and Stress Resistance in ARPE-19 Cells Through PKM2 Function.

Silvia Ravera, Alessandra Puddu, Nadia Bertola

|Nov 27, 2024
Redox Imbalance and Antioxidant Defenses Dysfunction: Key Contributors to Early Aging in Childhood Cancer Survivors.

Vanessa Cossu, Nadia Bertola, Chiara Fresia

|Sep 23, 2024
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study.

Ennio Nano, Francesco Reggiani, Adriana Agnese Amaro

Pageof 5

Frequent Collaborators

17 joint publications

Silvia Ravera

5 joint publications

Stefano Regis

4 joint publications

Giovanna Cutrona

4 joint publications

Maurizio Viale